Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Astrocytoma 3Oligodendroglioma 2Glioma 2Brain Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Glioma, Subependymal 1Ependymoma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 7Antilymphocyte Serum 7fludarabine phosphate 6Rituximab 6Filgrastim 6romidepsin 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Flow Cytometry 5Vorinostat 4Tacrolimus 4Gemcitabine 4Etoposide 4Cyclosporine 4Busulfan 4Bortezomib 4tanespimycin 3belinostat 3Whole-Body Irradiation 3Methylprednisolone 3Methotrexate 3Melphalan 3Lenalidomide 3Cord Blood Stem Cell Transplantation 3plerixafor 2nelarabine 2cobomarsen 2carfilzomib 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, T-Cell, Cutaneous × O(6)-benzylguanine × Clear all
NCT00003613 2013-01-11

O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma

National Cancer Institute (NCI)

Phase 1 Terminated
20 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡